DTL
TRDA icon

Dynamic Technology Lab’s Entrada Therapeutics TRDA Stock Holding History

Dynamic Technology Lab’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,474
Closed -$208K – 1093
2026
Q1 		$208K Sell
16,474
-8,828
-35% -$101K 0.03% 731
2025
Q4 		$260K Buy
+25,302
New +$213K 0.06% 534
2025
Q3 		– Sell
-24,734
Closed -$166K – 1223
2025
Q2 		$166K Buy
+24,734
New +$199K 0.02% 819

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Dynamic Technology Lab's TRDA Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Entrada Therapeutics (TRDA) in Q2 2026, closing a stake of 16,474 shares — an estimated $208K sold.

Dynamic Technology Lab first reported a position in TRDA in Q2 2025 and held it in 3 quarters. The position peaked at $260K in Q4 2025. 129 funds tracked by Wall St. Rank hold TRDA as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Entrada Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 16,474 Entrada Therapeutics shares in Q2 2026, an estimated $208K.
  • Dynamic Technology Lab first reported a position in Entrada Therapeutics in Q2 2025 and held it in 3 quarters.
  • Dynamic Technology Lab's Entrada Therapeutics position peaked at $260K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.